SYNTHETIC BIOLOGY - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Synthetic Biology in US$ Thousands by the following Product Segments: Enabled Products, and Others. The report also analyzes the market by the following Application Areas: Energy and Chemicals, Biotechnology and Pharmaceuticals, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 51 companies including many key and niche players such as -

Amyris, Inc.
BP PLC
Chromatin Inc.
Evolva SA
Gevo, Inc.


Click here to request a full list of companies covered in the report...

Code: MCP-6581
Price: $4950
Companies: 51
Pages: 240
Date: February 2015
Market Data Tables: 45
Status: * New Report

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   A Quick Primer.....II-1
Synthetic Biology: Prediction Becoming Reality.....II-1
2$200
   Current and Future Analysis.....II-3
Analysis by Region.....II-3
1$100
   Analysis by Product Segment.....II-4
Analysis by End-Use Market.....II-4
1$100
   Key Growth Drivers and Major Concerns.....II-5
Growth Drivers.....II-5
Major Concerns.....II-5
1$100
   Future Outlook.....II-61$100
   Synthetic Biology – An Emerging Discipline in Need of Promotion.....II-7
Contribution of Synthetic Biology to Biotech.....II-7
Craig Venter’s Synthetic Life: Momentous Achievement in Synthetic Biology
  Field.....II-7
1$100
   Gibson Assembly®: Building Toolset for Synthetic Biology.....II-8
Gen9’s BioFab: Major Breakthrough in Synthetic Biology.....II-8
1$100
   Key Developments in the Synthetic Biology Field: A Synopsis.....II-92$200
   Synthetic Biology Products with Commercial Potential in the Future by End
  Market.....II-11
1$100
   Competitive Landscape.....II-12
Competition in Synthetic Biology Market.....II-12
1$100
   Intrexon: Leader in Synthetic Biology Field.....II-13
Key Factors Contributing to Intrexon’s Success in Synthetic Biology Field.....II-13
Proprietary Suite of Innovative Technologies.....II-13
1$100
   Unique ECC-based Business Model.....II-141$100
   A Synopsis of Intrexon’s ECC Agreements: 2011-2013.....II-151$100
   Is Synthetic Biology a Bane or Boon?.....II-16
Synthetic Biology Exhibits Plateau in Awareness.....II-16
Synthetic Biology Research Gathers Momentum.....II-16
1$100
   US and Europe - Propelling Research in the Field of Synthetic Biology.....II-17
Table 1: Number of Entities Focused on Synthetic Biology Research Globally: 2009 & 2013 (includes corresponding Graph/Chart).....II-17
1$350
   Table 2: Synthetic Biology and their Potential Areas of Applications Being Researched by Biological Systems Manufacturers/Designers (includes corresponding Graph/Chart).....II-181$350
   Table 3: Number of Biological Systems Manufacturers/Designers Focused on Specialty/Fine Chemical Applications (includes corresponding Graph/Chart).....II-191$350
   Table 4: Number of Patent Filings Related to Synthetic Biology: 2003-2013 (includes corresponding Graph/Chart).....II-201$350
   Table 5: Leading Filers of Patent Applications Related to Synthetic Biology: 2003-2013 (includes corresponding Graph/Chart).....II-211$350
   Synthetic Biology Mired by Challenges in Developing Countries.....II-22
Synthetic Biology Bringing a Paradigm Shift in the Field of Biological
  Research.....II-22
1$100
   DNA Sequencing Technique Propelling Growth for Synthetic Biology.....II-23
Plummeting Cost of DNA Sequencing Bolsters Market Growth.....II-23
1$100
   Table 6: Cost per Genome Sequencing: 2001-2014.....II-24
Systems Biology Leading to Advancements in Synthetic Biology.....II-24
Synthetic Biology based Microbial Factories for Production of Poppies.....II-24
1$350
   Food and Other Basic Needs’ Scarcity to Fuel Synthetic Biology Market.....II-25
Food, Water, and Energy Statistics.....II-25
1$100
   Table 7: Top 20 Countries Worldwide in Terms of Population in Million (2014) (includes corresponding Graph/Chart).....II-26
Will Synthetic Biology Mitigate Food Security Concerns?.....II-26
1$350
   Growing Demand for GM Crops Opens Up Growth Avenues.....II-271$100
   Synthetic Biology-based Ingredients Gain Traction.....II-28
Role of Synthetic Biology in Producing Plants with Desirable Characteristics.....II-28
1$100
   Do-It-Yourself Biology (DIYBio): A Growing Phenomenon.....II-291$100
   Synthetic Biology Ingredients in Consumer Products - Laden with Concerns.....II-30
Synthetic Biology Gaining Prominence in Biomedical Applications.....II-30
1$100
   Research Efforts in Full Swing to Treat Life-Threatening Diseases using Synthetic
  Biology.....II-31
1$100
   Synthetic Biology Therapeutics to Address Antibiotic-Resistance Crisis.....II-321$100
   Pipeline Perspective of Synthetic Biology Therapeutics (Synthetic Biologics and
  Intrexon Collaboration).....II-33
Synthetic Biology for Wildlife Conservation Laden with Risks.....II-33
Synthetic Biology Enabling Creation of Advanced Biosensing Systems.....II-33
1$100
   Synthetic Biology Gains Significance in Production of Bio-Based Chemicals and
  Biofuels.....II-34
1$100
   Contribution of Synthetic Biology to Renewable Chemicals.....II-352$200
   Synthetic Biology for Energy Supply: Potential Threat to Biodiversity.....II-37
SynBio Products and Ingredients Face Opposition from Several Organizations.....II-37
1$100
   Lack of Regulatory Framework - A Major Concern.....II-381$100
   Biologists Implants Artificial Chromosome in Yeast to Create Artificial Life.....II-39
Synthetic Genes to Open New World of Drug Development.....II-39
1$100
   Researchers Announce Production of Peptoid Nanosheets.....II-40
Synthetic Biology in Repelling Viruses.....II-40
Synthetic Biology in Engineered Food.....II-40
1$100
   Synthetic Biology to Address Issues Related to Algal Blooms.....II-41
Synthetic Biology Holds Potential for Testing Water Purity.....II-41
Mars – A Home Away from Home Courtesy Synthetic Biology.....II-41
Predictable Biological Systems - No More a Myth.....II-41
Researchers at JCVI Make Novel Advances in Synthetic Genomics.....II-41
1$100
   Synthetic Biology Tools Can Detect Listeria Contamination in Food Products.....II-42
Synthetic Biology Accelerates Flu Vaccine Production.....II-42
1$100
   Bioengineers at Duke University Develops Novel System for Reproducing Natural Complex
  Gene Regulation.....II-43
TALE: A Viable Technology for Synthetic Protein Development.....II-43
Can Synthetic Biology Fuel Cars or Household Power Supplies Using Naturally-Existing
  Fatty Acids?.....II-43
1$100
   Researchers Engineered Synthetic Compound to Defend Iron Deficiency.....II-44
Cellular Circuit Designing Made Possible through Biological Genes.....II-44
1$100
   Meshing Inputs/Outputs Offer Layered Circuits.....II-45
Cambrian Genomics Pioneers DNA Laser Printer.....II-45
Researchers Develop Novel Technique that Speeds the Process for Developing New
  Biological Parts.....II-45
1$100
   Researchers Develop Novel Biological Device that Mimics Transistor-Like
  Properties.....II-46
1$100
   Introduction.....II-47
Historical Background.....II-47
Synthetic Biology Vis-à-vis Genetic Engineering - A Comparison.....II-47
1$100
   Scope of Synthetic Biology in Various Fields.....II-48
Engineering.....II-48
Chemistry.....II-48
Major Enabling Technologies.....II-48
Sequencing.....II-48
1$100
   Fabrication.....II-49
Modeling.....II-49
Measurement.....II-49
Synthetic Biology Market – By Product.....II-49
Core Products/Biologic Components.....II-49
Synthetic Genes.....II-49
1$100
   Synthetic Cells.....II-50
Chassis Organisms.....II-50
1$100
   Escherichia coli.....II-51
Bacillus subtilis.....II-51
Yeast.....II-51
Mycoplasma.....II-51
Acinetobacter.....II-51
Mycoplasma genitalium.....II-51
XNA (Xeno Nucleic Acid).....II-51
1$100
   Enabling Products.....II-52
DNA Synthesis.....II-52
Oligonucleotide Synthesis.....II-52
1$100
   Market Potential.....II-53
Pharmaceutical.....II-53
Industrial.....II-53
Agriculture.....II-53
Life Sciences Research.....II-53
Renewable Energy.....II-53
1$100
   Synthetic Biology Applications/Products with Highest Potential for Commercialization
  by 2030.....II-54
Potential Uses.....II-54
1$100
   Biomedicine.....II-55
Intricate Molecular Devices Utilized for Tissue Regeneration/Repair.....II-55
Smart Drugs.....II-55
Biological Delivery Systems.....II-55
Vectors for Therapy.....II-55
Personalized Medicine.....II-55
Cells with Novel Properties for Betterment of Human Health.....II-55
1$100
   In Vivo Synthesis of Small-Molecule Pharmaceuticals.....II-56
Intricate Natural Products.....II-56
Expansion of Chemistry of Life.....II-56
Expanding Genetic Alphabet.....II-56
Nucleic Acids.....II-56
1$100
   Proteins.....II-57
New Imaging and Targeting Methods.....II-57
Chemical Industry Sustainability.....II-57
Eco-friendly Production of Chemicals.....II-57
Energy and Environment.....II-57
Bioremediation.....II-57
Energy Production.....II-57
Biomaterials and Smart Materials Production.....II-57
1$100
   Synthesis.....II-58
Organization.....II-58
Socio-Economic Concerns and Risks of Synthetic Biology.....II-58
Production of Bio-Weapons.....II-58
Accidental Release.....II-58
Return on Investment.....II-58
Dissonance with Other Disciplines.....II-58
1$100
   Continuous Evolution.....II-59
Curtailed Understanding.....II-59
Unpredictable Ecosystem Effects.....II-59
Unexpected Transfer of Genes.....II-59
Aggravating Problems.....II-59
Industry Associations.....II-59
Synthetic Biology Industry Association (SynBIA).....II-59
1$100
   Industry Association of Synthetic Biology (IASB).....II-601$100
   Synthetic Biologics Obtains Orphan Drug Designation for SYN-005 mAb.....II-61
Agilent Technologies Introduces SureGuide Kits.....II-61
Agilent Technologies Rolls Out ClearSeq AML Next-Generation Sequencing Cancer
  Research Panels.....II-61
Gen9 Rolls Out Variant Libraries.....II-61
Gen9 Introduces GeneByte Plus™ DNA Constructs.....II-61
Agilent Technologies Introduces SureSelect Clinical Research Exome.....II-61
1$100
   Agilent Technologies Launches QuikChange HT Protein Engineering Synthetic Biology
  System.....II-62
GenScript Introduces GenEZ™ Next-Generation Molecular Cloning Service.....II-62
DNA2.0 Releases CRISPR/Cas9 Tools for Genome Editing and Engineering.....II-62
GenScript Unveils GenPlus™ Next-Generation Gene Synthesis Technology.....II-62
Life Technologies Introduces new GeneArt® Algae Protein Expression Kits.....II-62
Life Technologies Unveils Vector NTI® Express Designer Bioinformatics Software
  Platform.....II-62
Gen9 Introduces GeneBytes™ DNA Constructs.....II-62
1$100
   New England Biolabs and Synthetic Genomics Launches Gibson Assembly Cloning Kit and
  NEBuilder™ Primer Design Tool.....II-63
GenScript Introduces Gene-Brick™ Gene Synthesis Service.....II-63
1$100
   Genome Compiler Enters into Collaborative Agreement with DNA2.0.....II-64
Eurofins Genomics Enters into Co-operation Agreement with Igenbio.....II-64
Bacterial Robotics Signs Strategic Agreement with Bacmine.....II-64
Intrexon and Histogenics Enter into Exclusive Channel Collaboration for Cartilage
  Repair Therapies.....II-64
Intrexon and Amneal Pharmaceuticals Announce Second Exclusive Channel Collaboration
  for a Target API.....II-64
Synthetic Biologics and FUJIFILM Diosynth Biotechnologies Announces Positive Phase I
  Outcomes of API Manufacturing of SYN-004.....II-64
1$100
   Evolva Holding Acquires Prosarix.....II-65
Igenbio Collaborates with Genome Compiler.....II-65
Pareto Biotechnologies Enters into Technology Partnership with DNA2.0.....II-65
Roche Enters into Research Agreement with Stratos Genomics.....II-65
Cellectis Enters into Agreement with Thermo Fisher Scientific.....II-65
Roche Acquires Genia Technologies.....II-65
Synthorx, a New Synthetic Biotechnology Company Launches.....II-65
Synthetic Genomics Enters into Long-Term R&D Agreement with Lung Biotechnology.....II-65
1$100
   OriGene Introduces Genome-wide Gene-knockout Kits.....II-66
Intrexon Concludes Acquisition of Medistem.....II-66
Amyris Enters into Collaborative R&D Agreement with BASF.....II-66
MIT SBC Collaborates with Pfizer.....II-66
Tauriga Sciences Acquires Pilus Energy LLC.....II-66
OvaScience and Intrexon Enter into Agreement.....II-66
Sanofi Commences Large-Scale Production of Semi-Synthetic Artemisinin.....II-66
1$100
   EVOLVA and IFF Enter into Pre-Manufacturing Phase for Natural Vanillin.....II-67
Synthetic Genomics Enters into Research Agreement with ExxonMobil.....II-67
Amyris Signs Long Term Agreement with International Flavors & Fragrances.....II-67
SGI-DNA and IDT Announce Expanded Collaboration.....II-67
College of Engineering Establishes BU Center of Synthetic Biology.....II-67
Gen9 Enters into Partnership with Agilent Technologies.....II-67
AquaBounty Technologies Enters into Exclusive Channel Collaboration with
  Intrexon.....II-67
Synthetic Biologics Collaborates with Intrexon for Infectious Disease
  Therapies.....II-67
1$100
   DuPont Collaborates with OligoCo.....II-68
DNA2.0 Collaborates with Newcastle University.....II-68
Amyris Secures Contract from the US DARPA.....II-68
Pfenex Collaborates with DNA2.0.....II-68
Synthetic Genomics Inks Agreement with New England Biolabs.....II-68
Amyris Commences Production of Biofene in Brazil.....II-68
1$100
   Players Focused on Synthetic Biology Applications.....II-69
Amyris, Inc. (US).....II-69
1$100
   BP PLC. (UK).....II-70
Chromatin Inc. (US).....II-70
1$100
   Evolva SA (Switzerland).....II-71
Gevo, Inc. (US).....II-71
1$100
   Joule Unlimited, Inc. (US).....II-72
Metabolix (US).....II-72
MorphoSys AG (Germany).....II-72
1$100
   Sapphire Energy, Inc. (US).....II-73
Solazyme, Inc. (US).....II-73
Synthetic Biologics, Inc. (US).....II-73
1$100
   Synthetic Genomics, Inc. (US).....II-74
Players Focused on Gene Synthesis and Tools.....II-74
454 Life Sciences (US).....II-74
1$100
   Agilent Technologies Inc. (US).....II-75
ATG Biosynthetics GmbH (Germany).....II-75
1$100
   DNA2.0 (US).....II-76
Epoch Life Science, Inc. (US).....II-76
1$100
   Gen9, Inc. (US).....II-77
GenScript USA, Inc. (US).....II-77
1$100
   Gingko Bioworks, Inc. (US).....II-78
Intrexon Corporation (US).....II-78
1$100
   LC Sciences LLC (US).....II-79
Life Technologies Corp. (US).....II-79
1$100
   OPXBIO, Inc. (US).....II-80
OriGene Technologies, Inc. (US).....II-80
1$100
   Sangamo BioSciences, Inc. (US).....II-81
Verdezyne, Inc. (US).....II-81
1$100
   Table 8: World Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-821$350
   Table 9: World Historic Review for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-831$350
   Table 10: World 14-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-841$350
   Table 11: World Recent Past, Current & Future Analysis for Synthetic Biology by Product Segment - Enabled Products and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-851$350
   Table 12: World Historic Review for Synthetic Biology by Product Segment - Enabled Products and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-861$350
   Table 13: World 14-Year Perspective for Synthetic Biology by Product Segment - Percentage Breakdown of Dollar Sales for Enabled Products and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-871$350
   Table 14: World Recent Past, Current & Future Analysis for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....II-881$350
   Table 15: World Historic Review for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....II-891$350
   Table 16: World 14-Year Perspective for Synthetic Biology by End-Use Sector - Percentage Breakdown of Dollar Sales for Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....II-901$350
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Research in the US.....III-1
Table 17: Number of Entities Focused on Synthetic Biology Research in the US (2009 & 2013) (includes corresponding Graph/Chart).....III-1
1$200
   International Genetically Engineered Machine (IGEM) – A Platform for
  Innovations.....III-2
Product Launches.....III-2
2$150
   Strategic Corporate Developments.....III-45$375
   Key Players.....III-910$750
   B. Market Analytics.....III-19
Table 18: US Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-19
1$200
   Table 19: US Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-201$200
   Market Analysis.....III-21
Table 20: Canadian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-21
1$200
   Table 21: Canadian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-221$200
   Market Analysis.....III-23
Table 22: Japanese Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-23
1$200
   Table 23: Japanese Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-241$200
   A. Market Analysis.....III-25
Current & Future Analysis.....III-25
Research in Europe.....III-25
1$75
   Table 24: Number of Entities Focused on Synthetic Biology Research in Europe (2009 & 2013) (includes corresponding Graph/Chart).....III-261$200
   Table 25: Number of Entities Focused on Synthetic Biology Research by Area of Interest: 2013 (includes corresponding Graph/Chart).....III-271$200
   B. Market Analytics.....III-28
Table 26: European Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-28
1$200
   Table 27: European Historic Review for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-291$200
   Table 28: European 14-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).....III-301$200
   A. Market Analysis.....III-31
Current & Future Analysis.....III-31
Strategic Corporate Development.....III-31
1$75
   B. Market Analytics.....III-32
Table 29: French Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-32
1$200
   Table 30: French Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-331$200
   A. Market Analysis.....III-34
Current & Future Analysis.....III-34
Key Players.....III-34
1$75
   B. Market Analytics.....III-35
Table 31: German Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-35
1$200
   Table 32: German Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-361$200
   Market Analysis.....III-37
Table 33: Italian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-37
1$200
   Table 34: Italian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-381$200
   A. Market Analysis.....III-39
Current & Future Analysis.....III-39
Market Overview.....III-39
UK Government Awards Over £6 Million Grant For Synthetic Biology.....III-39
1$75
   Uk Government Funding For Synthetic Biology: 2013.....III-40
Synbicite Centre to Spearhead UK Research In Synthetic Biology.....III-40
UK Sets Up New Synthetic Biology Research Centers.....III-40
Synthetic Biology Research Centre Nottingham (Sbrc Nottingham).....III-40
1$75
   Bristol Centre for Synthetic Biology (Brissynbio).....III-41
Openplant Synthetic Biology Research Centre.....III-41
University of Edinburgh inks Agreement with BGI to Develop Artificial Yeast
  Genome.....III-41
Strategic Corporate Development.....III-41
1$75
   BP Plc. - A Key Player.....III-421$75
   B. Market Analytics.....III-43
Table 35: UK Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-43
1$200
   Table 36: UK Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-441$200
   A. Market Analysis.....III-45
Current & Future Analysis.....III-45
Strategic Corporate Development.....III-45
1$75
   B. Market Analytics.....III-46
Table 37: Spanish Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart).....III-46
1$200
   Table 38: Spanish Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-471$200
   A. Market Analysis.....III-48
Current & Future Analysis.....III-48
Evolva Sa (Switzerland) – A Major Player.....III-48
1$75
   B. Market Analytics.....III-49
Table 39: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-49
1$200
   Table 40: Rest of Europe Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
Current & Future Analysis.....III-51
Table 41: Number of Entities Focused on Synthetic Biology Research in Asia and Oceania in 2013 (includes corresponding Graph/Chart).....III-51
1$200
   B. Market Analytics.....III-52
Table 42: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-52
1$200
   Table 43: Asia-Pacific Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-531$200
   A. Market Analysis.....III-54
Current & Future Analysis.....III-54
Strategic Corporate Development.....III-54
1$75
   B. Market Analytics.....III-55
Table 44: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).....III-55
1$200
   Table 45: Rest of World Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).....III-561$200
  
Total Companies Profiled: 38 (including Divisions/Subsidiaries - 39)

Region/Country Players

The United States 30 Canada 1 Europe 6 France 1 Germany 3 The United Kingdom 1 Rest of Europe 1 Asia-Pacific (Excluding Japan) 2
Click here to request a full table of contents and more details on this project.